170
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe

, , , , , , , , & show all
Pages 997-1007 | Received 14 Mar 2023, Accepted 20 Jun 2023, Published online: 28 Jun 2023

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
  • Zaydfudim VM, Vachharajani N, Klintmalm GB, et al. Liver resection and transplantation for patients with hepatocellular carcinoma beyond Milan criteria. Ann Surg. 2016;264(4):650–658. doi:10.1097/SLA.0000000000001866
  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
  • European Association for the Study of The Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943. doi:10.1016/j.jhep.2011.12.001
  • Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234(1):71–78. doi:10.1097/00000658-200107000-00011
  • Xu H, Liu F, Hao X, et al. Laparoscopically anatomical versus non-anatomical liver resection for large hepatocellular carcinoma. HPB. 2020;22(1):136–143. doi:10.1016/j.hpb.2019.06.008
  • Liu Y, Dai Y, Zhang XX, Li SM, Liu RJ, Fan H. Comparative analysis of anatomic and non-anatomic hepatectomy for single small hepatocellular carcinoma with microvascular invasion. Zhonghua Yi Xue Za Zhi. 2018;98(24):1937–1940. Chinese. doi:10.3760/cma.j.issn.0376-2491.2018.24.009
  • Kobayashi A, Miyagawa S. Left hepatectomy. J Hepatobiliary Pancreat Sci. 2012;19(1):38–43. doi:10.1007/s00534-011-0452-z
  • Belli G, Fantini C, D’Agostino A, Belli A, Cioffi L, Russolillo N. Laparoscopic left lateral hepatic lobectomy: a safer and faster technique. J Hepatobiliary Pancreat Surg. 2006;13(2):149–154. doi:10.1007/s00534-005-1023-y
  • Zou J, Li S, Wang Q, et al. Surgical strategies for hepatocellular carcinoma located in the left lateral lobe: a propensity score-matched and prognostic nomogram study. Cancer Med. 2021;10(10):3274–3287. doi:10.1002/cam4.3894
  • Yang T, Lu JH, Lau WY, et al. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: a propensity score matching analysis. J Hepatol. 2016;64(3):583–593. doi:10.1016/j.jhep.2015.10.012
  • de Franchis R; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53(4):762–768. doi:10.1016/j.jhep.2010.06.004
  • Aoki T, Kubota K, Hasegawa K, et al. Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma. Br J Surg. 2020;107(1):113–120. doi:10.1002/bjs.11329
  • Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48(4):541–549. doi:10.1097/00000658-190810000-00005
  • Chen MY, Juengpanich S, Hu JH, et al. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma. World J Gastroenterol. 2020;26(10):1042–1055. doi:10.3748/wjg.v26.i10.1042
  • Wang H, Yu H, Qian YW, Cao ZY, Wu MC, Cong WM. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2021;20(3):232–239. doi:10.1016/j.hbpd.2020.12.018
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae
  • Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245(1):36–43. doi:10.1097/01.sla.0000231758.07868.71
  • Yang P, Si A, Yang J, et al. A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion. Surgery. 2019;165(4):721–730. doi:10.1016/j.surg.2018.09.016
  • Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005;201(5):656–662. doi:10.1016/j.jamcollsurg.2005.05.027
  • Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. 2019;26(5):1474–1493. doi:10.1245/s10434-019-07227-9
  • Subbotin VM. Privileged portal metastasis of hepatocellular carcinoma in light of the coevolution of a visceral portal system and liver in the chordate lineage: a search for therapeutic targets. Drug Discov Today. 2018;23(3):548–564. doi:10.1016/j.drudis.2018.01.020
  • Mansi J, Morden J, Bliss JM, Neville M, Coombes RC. Bone marrow micrometastases in early breast cancer-30-year outcome. Br J Cancer. 2016;114(3):243–247. doi:10.1038/bjc.2015.447
  • Sasaki E, Nagino M, Ebata T, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244(1):99–105. doi:10.1097/01.sla.0000217675.22495.6f
  • Cheng Z, Yang P, Qu S, et al. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. HPB. 2015;17(5):422–427. doi:10.1111/hpb.12367
  • Bruix J, Han KH, Gores G, Llovet JM, Mazzaferro V. Liver cancer: approaching a personalized care. J Hepatol. 2015;62(1 Suppl):S144–S156. doi:10.1016/j.jhep.2015.02.007
  • Wang YY, Zhong JH, Xu HF, et al. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria. Aliment Pharmacol Ther. 2019;49(2):202–210. doi:10.1111/apt.15074
  • Wada H, Eguchi H, Noda T, et al. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinomas. Surgery. 2016;160(5):1227–1235. doi:10.1016/j.surg.2016.05.023
  • Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis b virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151(4):356–363. doi:10.1001/jamasurg.2015.4257
  • Shi C, Zhao Q, Liao B, et al. Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis. ANZ J Surg. 2019;89(11):E482–E486. doi:10.1111/ans.15396
  • Kokudo T, Hasegawa K, Shirata C, et al. Assessment of preoperative liver function for surgical decision making in patients with hepatocellular carcinoma. Liver Cancer. 2019;8(6):447–456. doi:10.1159/000501368